Products

Rapid MLS
RapidAI
Neurology AI
Rapid MLS by iSchemaview (RapidAI) is an AI-powered software that analyzes non-contrast CT scans to measure and visually display brain midline shifts, aiding in the assessment of intracranial hemorrhage and traumatic brain injury.

See all 1 product →

About iSchemaview, Inc. (operating as RapidAI)

RapidAI, operating under iSchemaview, Inc., is a leading healthcare AI company that develops deep clinical artificial intelligence software for medical imaging analysis. This platform goes beyond basic detection, offering deeper insights and supporting more informed decisions in critical care scenarios.

For physicians, RapidAI’s solutions are particularly impactful in time-sensitive situations. The platform offers AI-driven triage, localization, quantification, characterization, and 3D visualization capabilities for conditions such as stroke (both hemorrhagic and ischemic), aneurysm, pulmonary embolism, and general radiology cases. The mobile app facilitates real-time alerts, case collaboration, DICOM viewer integration, EMR connectivity, and initiation of procedural workflows, enabling faster and more confident decisions by connecting radiology, specialists, and care teams. The company emphasizes its extensive clinical validation, with over 700 peer-reviewed publications and more than 25 clinical trials supporting its technology, including research that contributed to updated national stroke-treatment guidelines.

Focus Areas

neurovascular imaging stroke detection aneurysm management aortic disease pulmonary embolism deep clinical AI medical imaging analysis clinical decision support patient workflow enterprise imaging

Business Intelligence

Technologycloud-native (Rapid Edge Cloud), AI operating system (Rapid Enterprise Platform), deep clinical AI, integrated partner AI

What Physicians Need to Know

Neurovascular Expertise
RapidAI offers a comprehensive suite of AI-driven solutions for neurovascular assessment, including ischemic stroke (NCCT Stroke, ASPECTS, Hypodensity, Rapid LMVO, Rapid CTA, Perfusion Imaging, AngioFlow), hemorrhagic stroke (Rapid ICH, Rapid ASPECTS, Hyperdensity, SDH, MLS, OH, DeltaFuse), and aneurysm detection, growth assessment, and longitudinal tracking.
Cardiac & Vascular Solutions
Specializes in AI-powered solutions for cardiac and vascular conditions, including automated measurements and renderings for aortic assessment and surveillance (Rapid Aortic), and suspected and incidental pulmonary embolism (PE) detection and severity stratification (Rapid PE).
Radiology Support
Provides AI for interpretation, workflows, and care team collaboration for radiologists, offering tools for case prioritization, AI interpretation assistance, autoreporting, and connectivity (Navigator Pro). It delivers AI-driven insights across neurovascular, aortic, spine, chest, and cardiothoracic imaging.
Life Sciences
Supports life sciences with imaging biomarker automation, patient identification, and trial analytics.
Clinical Decision Support
Offers deep clinical AI that goes beyond detection to surface deeper insights, providing decision-grade analysis, quantification, and clinical context to support more informed decisions across various disease states.
Workflow Optimization & Care Coordination
Connects radiology, specialists, and care teams for faster, more confident decisions through real-time collaboration, alerts, in-app messaging, and shared imaging insights. It aims to reduce delays, improve alignment, and accelerate time to treatment.
Enterprise Imaging & Platform
The Rapid Enterprise™ Platform is a vendor-agnostic, secure, and scalable infrastructure that deploys deep clinical AI across the health system, connecting imaging to clinical action. It supports cross-disciplinary deployment of AI and integrates with existing IT infrastructure.
Physician Tip

For physicians, RapidAI stands out by providing decision-grade analysis, quantification, and clinical context from imaging to action, enabling faster and more confident decisions. Its deep clinical AI goes beyond simple detection to offer specific, relevant, and contextual data with high accuracy (e.g., 98.1% sensitivity/99.7% specificity for ICH and 97% sensitivity/96% specificity for LVO). The platform helps reduce cognitive burden by streamlining workflows, automating tasks like 3D reconstructions and AI measurements for reports, and integrating findings directly into existing systems. This allows radiologists to read faster and easier, while care teams can act more quickly with shared insights and real-time collaboration. RapidAI's solutions have been instrumental in expanding the treatment window for acute stroke patients from 6 to 24 hours, based on research that contributed to updated national stroke-treatment guidelines.

RapidAI's Rapid Enterprise™ Platform is designed for seamless integration with existing healthcare IT infrastructure. It offers vendor-agnostic integration and connects with PACS, EHR systems, RIS, worklist providers (or DICOM-based worklist prioritization), standard (HL7, FHIR, DICOM) and custom APIs, and communication platforms. The platform also supports the integration of trusted third-party AI algorithms.

Products by iSchemaview, Inc. (operating as RapidAI)

1 product in the directory

Rapid MLS
RapidAI
Neurology AI
Rapid MLS by iSchemaview (RapidAI) is an AI-powered software that analyzes non-contrast CT scans to measure and visually display brain midline shifts, aiding in the assessment of intracranial hemorrhage and traumatic brain injury.

Videos

News, demos, and interviews about iSchemaview, Inc. (operating as RapidAI).

Loading videos...

Videos load interactively. If none appear, search YouTube for iSchemaview, Inc. (operating as RapidAI) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

RapidAI's platform offers AI-powered solutions across various specialties, including neurovascular (ischemic stroke, hemorrhagic stroke, aneurysm), cardiac and vascular (aortic disease, pulmonary embolism), and radiology. The platform provides tools for viewing, processing, and analyzing CT and MRI images to aid in the assessment and treatment of these conditions, and also supports trauma care.
RapidAI's key products include the Rapid Enterprise Platform, which delivers deep clinical AI for enhanced decision-making, and the Rapid Mobile App for real-time collaboration and alerts. Other modules like Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS assist with advanced imaging analysis for stroke. The platform also features Navigator Pro for radiology prioritization and Rapid Insights for performance analytics, all designed to streamline workflows and improve care coordination.
RapidAI prioritizes data security and compliance, adhering to rigorous standards such as HIPAA, GDPR, ISO 13485, ISO 27001, ISO 27701, ISO 42001, SOC 2 Type 2, and CSA STAR. The platform is built using the National Institute of Standards and Technology (NIST) cybersecurity framework, ensuring a layered approach to threat neutralization and secure data management.
RapidAI does not publicly disclose its pricing. The company utilizes a quote-based pricing model, with contracts arranged directly with the vendor for hospitals and health systems. There are no free plans or trials listed, and pricing is customized based on the specific needs of the healthcare organization.
RapidAI provides 24/7/365 customer support globally via a hotline and email. They also offer RapidU, a role-based training and certification program with over 100 learning opportunities, including CE credits for select courses, to help care teams maximize their use of RapidAI technology and optimize workflows.
RapidAI, founded in 2011, has demonstrated sustained growth and profitability, raising a total of $100 million in funding over three rounds, including a $75 million Series C in 2023. The company has expanded its solutions beyond stroke to include aneurysm and pulmonary embolism, with ongoing development in other disease states. RapidAI is used in over 2,500 hospitals in more than 100 countries and is actively pursuing strategic partnerships and technology acquisitions to further its global reach and platform capabilities.
Yes, RapidAI's enterprise infrastructure is designed for standards-based interoperability with core health IT systems, including PACS, RIS, and EHRs. This allows for seamless integration of new AI capabilities without disrupting existing infrastructure and ensures that new tools can be deployed without adding operational burden.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.